AI & Emerging Technology

MedTech firm Lifeward is acquiring Oramed's oral insulin tech, despite a past trial failure, in a high-stakes deal that could redefine both companies.

Austrian firm AOP Health secures nationwide access for its rapid heart rate drug, Rapiblyk™, by partnering with top US distributors. What does this mean for critical care?

With a new name and a laser focus on its lead hemophilia A drug, Metagenomi Therapeutics signals a major shift from platform tech to clinical powerhouse.

Interim data suggests LX2020 is well-tolerated and may reduce dangerous arrhythmias by targeting the root cause of PKP2-associated cardiomyopathy.

With new funding, Nanochon is advancing its 3D-printed Chondrograft™ implant, offering hope for faster recovery to patients with chronic knee damage.

CoinEx's consistent token burning removes over 166M CET in a year, signaling a long-term commitment to scarcity and value in a competitive market.

Nominated for a top OCBJ award, Marla Noel’s journey from founder to growth advisor reveals a blueprint for 'drama free' success in business and community.

Gartner recognizes Jamf as a Leader in endpoint management, highlighting the growing dominance of specialized, Apple-centric solutions in the enterprise.

Pudu Robotics' new PUDU T150 aims to democratize factory automation with promises of fast deployment and lower costs for small and mid-sized businesses.

The P&C insurance tech leader leverages its strong cash position for a massive buyback, signaling confidence amid its successful cloud transformation.

A new report reveals Canada's rail sector hit record safety, invested $4.5B, and grew its high-paying workforce, proving its essential economic role.

The diversified company is pivoting to Web3, partnering to transform high-value memorabilia like sports cards and art into tradable digital assets.

Altus Group's annual ARGUS University Challenge opens registration, offering students a critical proving ground to master industry-standard software.

ZenaTech's rapid acquisitions signal a land grab in the booming Drone as a Service market, but can its high-risk, high-reward strategy pay off?

The cybersecurity firm renewed its multi-million dollar GRC contract with a Fortune 100 client, signaling deep trust and validating its market strategy.

Rani Therapeutics starts Phase 1 trials for an oral obesity drug, challenging the injectable market with a novel delivery system and a dual-action compound.

A European deep-tech firm emerges from stealth with a system that powers moving and rotating devices, aiming to untether robotics and spatial computing.

Proven Optics acquires brightfin, uniting IT finance and expense management on ServiceNow under new CEO Joel Martins to tackle rising global tech costs.

Roundtable's Web3 model is attracting top media talent and legacy brands, signaling a major disruption for sports content and the creator economy.

The new partnership combines Nuvei's global reach with FreedomPay's commerce platform, creating a single solution for omnichannel payments and customer data.